Clinical Trial

Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2024 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study was to prospectively collect clinical data from patients who underwent hepatic artery chemoembolization using microspheres with different degradation times (2 hours, 1 day, 2 weeks) based on standard treatment.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-09-28; most recent amendment 2024-11-12.
Status change: Not Yet Recruiting → Recruiting 2021-12-07
Trial Details
NCT Number NCT05072041
Lead Sponsor Next Biomedical Co., Ltd.
Conditions Hepatocellular Carcinoma
Enrollment 150 participants
Start Date 2021-10-31
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-14